Literature DB >> 34992271

Conditional immortalization of human atrial myocytes for the generation of in vitro models of atrial fibrillation.

Daniël A Pijnappels1, Antoine A F de Vries2, Niels Harlaar1,3, Sven O Dekker1, Juan Zhang1, Rebecca R Snabel4, Marieke W Veldkamp5, Arie O Verkerk5,6, Carla Cofiño Fabres7, Verena Schwach7, Lente J S Lerink1, Mathilde R Rivaud5, Aat A Mulder8, Willem E Corver9, Marie José T H Goumans8, Dobromir Dobrev10, Robert J M Klautz3, Martin J Schalij1, Gert Jan C Veenstra4, Robert Passier7, Thomas J van Brakel3.   

Abstract

The lack of a scalable and robust source of well-differentiated human atrial myocytes constrains the development of in vitro models of atrial fibrillation (AF). Here we show that fully functional atrial myocytes can be generated and expanded one-quadrillion-fold via a conditional cell-immortalization method relying on lentiviral vectors and the doxycycline-controlled expression of a recombinant viral oncogene in human foetal atrial myocytes, and that the immortalized cells can be used to generate in vitro models of AF. The method generated 15 monoclonal cell lines with molecular, cellular and electrophysiological properties resembling those of primary atrial myocytes. Multicellular in vitro models of AF generated using the immortalized atrial myocytes displayed fibrillatory activity (with activation frequencies of 6-8 Hz, consistent with the clinical manifestation of AF), which could be terminated by the administration of clinically approved antiarrhythmic drugs. The conditional cell-immortalization method could be used to generate functional cell lines from other human parenchymal cells, for the development of in vitro models of human disease.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34992271     DOI: 10.1038/s41551-021-00827-5

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN: 2157-846X            Impact factor:   29.234


  58 in total

1.  A versatile tool for conditional gene expression and knockdown.

Authors:  Jolanta Szulc; Maciej Wiznerowicz; Marc-Olivier Sauvain; Didier Trono; Patrick Aebischer
Journal:  Nat Methods       Date:  2006-02       Impact factor: 28.547

2.  Conditionally immortalized brown preadipocytes can switch between proliferative and differentiated states.

Authors:  Jia Liu; Eline N Kuipers; Hetty C M Sips; Jennifa C Dorleijn; Andrea D van Dam; Constantinos Christodoulides; Fredrik Karpe; Guangqian Zhou; Mariëtte R Boon; Patrick C N Rensen; Antoine A F de Vries; Sander Kooijman
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-08-26       Impact factor: 4.698

Review 3.  The current state of animal models in research: A review.

Authors:  N Bryce Robinson; Katherine Krieger; Faiza M Khan; William Huffman; Michelle Chang; Ajita Naik; Ruan Yongle; Irbaz Hameed; Karl Krieger; Leonard N Girardi; Mario Gaudino
Journal:  Int J Surg       Date:  2019-10-15       Impact factor: 6.071

4.  Tetracycline-reversible silencing of eukaryotic promoters.

Authors:  U Deuschle; W K Meyer; H J Thiesen
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

5.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

6.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

7.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

8.  Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.

Authors:  Sumeet S Chugh; Rasmus Havmoeller; Kumar Narayanan; David Singh; Michiel Rienstra; Emelia J Benjamin; Richard F Gillum; Young-Hoon Kim; John H McAnulty; Zhi-Jie Zheng; Mohammad H Forouzanfar; Mohsen Naghavi; George A Mensah; Majid Ezzati; Christopher J L Murray
Journal:  Circulation       Date:  2013-12-17       Impact factor: 29.690

9.  Generation and primary characterization of iAM-1, a versatile new line of conditionally immortalized atrial myocytes with preserved cardiomyogenic differentiation capacity.

Authors:  Jia Liu; Linda Volkers; Wanchana Jangsangthong; Cindy I Bart; Marc C Engels; Guangqian Zhou; Martin J Schalij; Dirk L Ypey; Daniël A Pijnappels; Antoine A F de Vries
Journal:  Cardiovasc Res       Date:  2018-12-01       Impact factor: 10.787

Review 10.  Coordinating cell proliferation and differentiation: Antagonism between cell cycle regulators and cell type-specific gene expression.

Authors:  Suzan Ruijtenberg; Sander van den Heuvel
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

View more
  4 in total

Review 1.  How Functional Genomics Can Keep Pace With VUS Identification.

Authors:  Corey L Anderson; Saba Munawar; Louise Reilly; Timothy J Kamp; Craig T January; Brian P Delisle; Lee L Eckhardt
Journal:  Front Cardiovasc Med       Date:  2022-07-04

2.  Improved Atrial Differentiation of Human Pluripotent Stem Cells by Activation of Retinoic Acid Receptor Alpha (RARα).

Authors:  Verena Schwach; Carla Cofiño-Fabres; Simone A Ten Den; Robert Passier
Journal:  J Pers Med       Date:  2022-04-13

3.  Integrative Computational Modeling of Cardiomyocyte Calcium Handling and Cardiac Arrhythmias: Current Status and Future Challenges.

Authors:  Henry Sutanto; Jordi Heijman
Journal:  Cells       Date:  2022-03-24       Impact factor: 6.600

4.  Numerical methods for the detection of phase defect structures in excitable media.

Authors:  Desmond Kabus; Louise Arno; Lore Leenknegt; Alexander V Panfilov; Hans Dierckx
Journal:  PLoS One       Date:  2022-07-12       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.